Sodium Glutamate Injection
Function and Efficacy
This product is an amino acid drug. In severe hepatitis or liver dysfunction, the liver's conversion of ammonia to urea is impaired, resulting in increased blood ammonia and encephalopathy symptoms. The intake of glutamate and arginine is beneficial to reduce and eliminate blood ammonia, thereby improving encephalopathy symptoms.
Ingredients
The main ingredient of this product is sodium glutamate, and its chemical name is: sodium L-2-aminoglutarate.
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| L-(+)Sodium glutamateIngredients |
In severe hepatitis or liver dysfunction, the liver's conversion of ammonia to urea is impaired, resulting in increased blood ammonia and encephalopathy symptoms. The intake of glutamate and arginine is beneficial to reduce and eliminate blood ammonia, thereby improving encephalopathy symptoms. More |
142-47-2 | 4 |
Appearance
This product is a colorless or almost colorless clear liquid.
Indication
Used for hepatic encephalopathy, hepatic coma and other mental symptoms caused by excessive blood ammonia.
Usage and Dosage
Intravenous drip: 11.5 g each time, not more than 23 g per day, diluted with 5% glucose injection and slowly dripped.
Adverse Reactions
1. When a large amount of sodium glutamate is used to treat hepatic encephalopathy, it can cause severe alkalosis and hypokalemia due to excessive absorption of sodium. Therefore, electrolyte concentrations must be closely monitored during treatment. 2. If the infusion is too fast, symptoms such as drooling, blushing, and vomiting may occur. 3. Precursors of allergies may include facial flushing, headache, and chest tightness. 4. Children may have tremors. 5. Patients with anxiety may experience syncope, tachycardia, and nausea after use.
Precautions
It is contraindicated for those who are allergic to this product.
Drug Interactions
Not yet clear.
Storage
Keep in dark place and sealed
Packaging Specification
20ml:5.75g
Manufacturer
Southwest Pharmaceutical Co., Ltd.
-
Founded in:
2015-01-08 -
Address:
No. 21 Tianxing Bridge, Shapingba District, Chongqing -
Tax NO.:
915000003316906249 -
Registered Funds:
490.146298 million yuan -
Website:
-
Email: